Weed (BUDZ) Amortizatization of Intangibles (2022 - 2026)
Weed (BUDZ) posted quarterly Amortizatization of Intangibles of $2564.0 for Q1 2026, little changed year-over-year from $2563.0 in Q1 2025, and little changed quarter-over-quarter from $2564.0 in Q4 2025.
Weed (BUDZ) Amortizatization of Intangibles (2022 - 2026) Analysis & Trends
Weed's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $2564.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles changed 0.04% year-over-year to $2564.0; the TTM figure through Mar 2026 stood at $10256.0 (up 44.51% YoY), while the FY2025 annual figure was $10255.0, changed 0.0% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $2564.0, roughly flat from $2564.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $47386.0 in Q2 2023, with the low at -$43094.0 in Q3 2023.
- The 5-year median for Amortizatization of Intangibles is $5621.0 (2024), against an average of $4364.3.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles surged 166.6% in 2023, then slumped 165.43% in 2024.
- Weed's Amortizatization of Intangibles stood at -$15396.0 in 2022, then soared by 166.6% to $10253.0 in 2023, then plunged by 165.43% to -$6709.0 in 2024, then surged by 138.22% to $2564.0 in 2025, then changed by 0.0% to $2564.0 in 2026.
- Business Quant data shows BUDZ's Amortizatization of Intangibles at $2564.0 in Q1 2026, $2564.0 in Q4 2025, and -$3552.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | 854.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,564.00 |
| Mar 31, 2026 | 2,564.00 |
| Dec 31, 2025 | 2,564.00 |
| Dec 31, 2025 | 2,564.00 |
| Sep 30, 2025 | -3,552.00 |
| Sep 30, 2025 | -3,552.00 |
| Jun 30, 2025 | 8,680.00 |
| Jun 30, 2025 | 8,680.00 |
| Mar 31, 2025 | 2,563.00 |
| Mar 31, 2025 | 2,563.00 |
| Dec 31, 2024 | -6,709.00 |
| Dec 31, 2024 | -6,709.00 |
| Sep 30, 2024 | 5,621.00 |
| Sep 30, 2024 | 5,621.00 |
| Jun 30, 2024 | 5,622.00 |
| Jun 30, 2024 | 5,622.00 |
| Mar 31, 2024 | 5,721.00 |
| Mar 31, 2024 | 5,721.00 |
| Dec 31, 2023 | 10,253.00 |
| Dec 31, 2023 | 10,253.00 |